Project
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with KRAS- and BRAF wild-type metastatic colorectal cancer. A multicenter phase II trial, Leit-EK Zürich
Aborted · 2013 until 2022
Horber Daniel, Gueller Ulrich, Diem Stefan